Skip to content
11,086 Devices Shipped.11,086 Shipped
Trusted by Scientists since 2019.Scientist Trusted
Recommended to their patients by doctors.Doctor Recommended
Vagally Understood

The science of getting better

The vagus nerve is vaguely understood by science. We're working on it. Here's what the research says about non-invasive vagus nerve stimulation, and why it matters for your health.

What the research shows

Transcutaneous auricular vagus nerve stimulation (taVNS) is a non-invasive technique that delivers gentle electrical pulses to the auricular branch of the vagus nerve at the ear. Over the past decade, a growing body of peer-reviewed research has explored its effects on autonomic function, inflammation, mood, sleep, and more.

We don't claim taVNS is a cure for anything. The research is encouraging, sometimes remarkably so, but it's still developing. What follows is an honest look at the evidence: what's strong, what's promising, and where the science still has work to do. We think that's a better approach than pretending all the answers are in.

109+ Clinical studies A 2024 scoping review identified taVNS studies across 21 different clinical populations
3,200+ Participants studied Across active and sham-controlled trials in the scoping review alone
0 Severe adverse events A systematic review found no causal link between taVNS and serious side effects

How non-invasive vagus nerve stimulation works

Your vagus nerve is the longest cranial nerve in your body, running from your brainstem to your abdomen and connecting to your heart, lungs, digestive system and immune organs along the way. A small branch of this nerve surfaces at the tragus of your ear, making it the only cranial nerve you can reach from outside the body. Learn more about the vagus nerve.

taVNS works by delivering low-intensity electrical pulses to this auricular branch. The signal travels along vagal afferent fibres to the brainstem, specifically the nucleus tractus solitarius (NTS) and the locus coeruleus (LC). From there, it influences autonomic balance, immune regulation, and brain regions involved in mood, stress, and cognition.

1 Ear electrode Gentle pulses stimulate the auricular branch of the vagus nerve at the tragus
2 Brainstem Signals ascend to the NTS and locus coeruleus, activating ascending and descending pathways
3 Autonomic shift Parasympathetic activity increases, rebalancing away from fight-or-flight
4 Whole-body effects HRV improves, inflammation reduces, mood and sleep shift for the better

Why current control matters

Your skin resistance changes constantly with temperature, moisture, and time of day. A voltage-controlled device delivers the same voltage regardless, meaning the actual current reaching your nerve fluctuates unpredictably. Our tVNS Stimulator is current-controlled: it measures resistance tens of thousands of times per second and adjusts output to maintain a consistent dosage. This is both safer and more consistent with the parameters used in published research.

Built for better

Every device we make is designed around the stimulation parameters used in published research. Current-controlled, adjustable, and compatible with the Vagal Tones protocol library.

A better measure of heart health

Heart rate variability (HRV) is the variation in time between consecutive heartbeats. Higher HRV reflects a nervous system that can flexibly adapt to changing demands: recovering quickly from stress, regulating blood pressure beat-to-beat, and coordinating the body's resources efficiently.

Low HRV is associated with increased risk of cardiovascular disease, diabetes, and all-cause mortality. It declines naturally with age, but research shows taVNS can push it in the right direction. Our Autonomic Rebalancing Tone is specifically designed for this.

Landmark study
15 minutes daily: the Leeds University study
Bretherton et al. | University of Leeds & Glasgow | Aging, 2019
51 healthy participants aged 55+. A single session of taVNS significantly increased multiple measures of vagal tone. Two weeks of daily 15-minute sessions improved autonomic function, quality of life, mood, and sleep. Those with the poorest baseline showed the most improvement.
Read the full paper
HRV & depression
Baseline HRV as a guide to taVNS response
De Smet et al. | Translational Psychiatry, 2025
120-participant crossover trial. Individuals with lower baseline RMSSD showed the greatest improvements in cardiac and inflammatory stress responses after taVNS. People with compromised autonomic function respond most strongly.
Read the full paper
Sympathetic activity
Non-invasive VNS reduces sympathetic nerve activity
Clancy et al. | University of Leeds | Brain Stimulation, 2014
Healthy volunteers received taVNS at the tragus. Direct microneurography recordings confirmed a significant reduction in muscle sympathetic nerve activity, providing objective physiological evidence that non-invasive stimulation shifts autonomic balance toward parasympathetic dominance.
Read the paper
Baroreflex
taVNS acutely improves cardiac baroreflex sensitivity
Antonino et al. | Brain Stimulation, 2017
Randomised, placebo-controlled trial in healthy young men. A single session of taVNS acutely improved spontaneous cardiac baroreflex sensitivity, the beat-to-beat blood pressure regulation mechanism that weakens with age and cardiovascular disease.
Read the paper

The body's natural brake on inflammation

In 2000, Kevin Tracey's laboratory discovered that stimulating the vagus nerve could dramatically reduce pro-inflammatory cytokines like TNF-alpha. They named this the cholinergic anti-inflammatory pathway.

When the vagus nerve detects inflammation, it releases acetylcholine which binds to alpha-7 nicotinic receptors on immune cells, suppressing inflammatory molecules. When vagal tone is low, this braking system weakens. Chronic low-grade inflammation is now recognised as a driver of cardiovascular disease, autoimmune conditions, and age-related decline.

Foundational
The cholinergic anti-inflammatory pathway
Tracey | Feinstein Institutes | Nature, 2002
The seminal work establishing that the efferent vagus nerve inhibits pro-inflammatory cytokine release and protects against systemic inflammation. Opened the door to neuromodulation as an anti-inflammatory strategy.
Read the paper
2026 Review
Cholinergic reflex control across inflammatory disorders
Han et al. | Frontiers in Immunology, 2026
Clinical trials now support taVNS use across rheumatoid arthritis, inflammatory bowel disease, gout, and systemic lupus, with emerging research into post-operative inflammation and metabolic syndrome.
Read the review

A better way to manage stress

When vagal tone is low, the stress response can feel like it never fully switches off. A 2023 meta-analysis of 12 randomised controlled trials involving 838 participants found that taVNS significantly reduced depression scores, with response rates comparable to antidepressant medication and fewer side effects.

The mechanism works through two routes: an ascending pathway modulates the locus coeruleus for arousal and mood control, while a descending pathway activates the cholinergic anti-inflammatory pathway, suppressing the pro-inflammatory cytokines linked to depression and anxiety.

Meta-analysis
taVNS efficacy in depressive disorder
Tan et al. | Journal of Affective Disorders, 2023
12 RCTs, 838 participants. taVNS significantly improved depression scores with response rates comparable to antidepressant medication. Combining taVNS with antidepressants showed comparable efficacy with fewer side effects.
Read the paper
Dual mechanism
taVNS for emotional dysregulation and neuroinflammation
Multiple authors | Brain Sciences, 2025
taVNS addresses both noradrenergic dysfunction and chronic inflammation in neuropsychiatric disorders via ascending and descending pathways, creating a dual therapeutic effect.
Read the paper
Key finding

The people who need it most, benefit most

One of the most consistent findings across taVNS research is that individuals with lower baseline vagal tone show the greatest response. This has been demonstrated in autonomic measures, inflammatory responses, and stress reactivity. taVNS appears to work hardest where the need is greatest.

Better nights, better days

The vagus nerve's role in shifting from sympathetic (alert) to parasympathetic (rest) dominance is fundamental to falling asleep and achieving deep, restorative sleep.

A 2024 randomised clinical trial in JAMA Network Open demonstrated meaningful improvements in chronic insomnia versus sham. A meta-analysis of six studies (336 patients) found improvements across sleep quality, latency, duration, and efficiency.

JAMA trial
taVNS for chronic insomnia disorder
JAMA Network Open, 2024
Significant improvements in insomnia severity versus sham stimulation, adding to the growing evidence for non-pharmacological sleep interventions.
Read the trial
Meta-analysis
Systematic review of taVNS in insomnia
de Oliveira et al. | Neuromodulation, 2025
Six studies, 336 patients. Improvements across PSQI and ISI scores, sleep latency, duration, and efficiency through neural modulation and autonomic regulation.
Read the review
Community RCT
Two weeks of tVNS improves global sleep quality
Jackowska et al. | Autonomic Neuroscience, 2022
Randomised trial in community-dwelling adults. Two weeks of daily transcutaneous vagal nerve stimulation produced significant improvements in global sleep quality scores, suggesting practical benefits achievable outside clinical settings.
Read the paper
Auricular RCT
taVNS at auricular concha for insomnia
Jiao et al. | Evidence-Based Complementary and Alternative Medicine, 2020
Randomised clinical trial examining taVNS at the auricular concha for insomnia. Participants receiving active stimulation showed significant improvements in sleep quality compared to sham, with sustained benefits over the treatment period.
Read the paper

Vagal tone can be improved at any age

Ageing is associated with a progressive shift: sympathetic activity increases while parasympathetic activity declines. The Leeds University study targeted participants aged 55+ and found daily taVNS improved autonomic function, quality of life, and mood within just two weeks.

Unlike many health markers, vagal tone responds well to intervention. Slow breathing, regular exercise, and targeted electrical stimulation have all been shown to measurably improve it. Even small improvements have significant positive effects on stress management, digestion, and sleep.

Cognitive ageing
tVNS impact on healthy cognitive and brain ageing
Trifilio et al. | Frontiers in Neuroscience, 2023
Examined the effects of transcutaneous vagus nerve stimulation on cognitive performance and brain health in ageing adults. Findings suggest tVNS may support healthy cognitive ageing through modulation of noradrenergic pathways and improved neural connectivity.
Read the paper
Memory
tVNS boosts associative memory in older adults
Jacobs et al. | Neurobiology of Aging, 2015
Older individuals receiving transcutaneous vagus nerve stimulation showed significantly improved associative memory performance compared to sham. The results point to a practical, non-pharmacological route for supporting memory function in ageing populations.
Read the paper

What the evidence says about safety

The first systematic review of taVNS safety (Harvard/Spaulding Rehabilitation Hospital) found no causal relationship between taVNS and severe adverse events. The most common side effects were mild and transient: occasional tingling, minor skin irritation, and in rare cases, brief headache.

As with any wellness intervention, we recommend consulting a healthcare professional before starting, particularly if you have implanted electrical devices, cardiac rhythm disorders, or are pregnant.

Where the science stands

Not all evidence is equal, and we think you should know where each area sits. Here's our honest assessment.

AreaEvidenceKey studiesOur take
Heart rate variabilityStrongMultiple RCTs, consistent replicationMost robustly supported effect. Measurable and consistent.
Autonomic balanceStrongBaroreflex sensitivity, sympathovagal shiftWell-documented across multiple measures.
DepressionStrong12 RCTs, 838 participantsConsistently positive, comparable to medication.
Anti-inflammatoryGrowingRA, IBD, gout clinical trialsMechanism well-understood. Clinical evidence accumulating.
Sleep qualityGrowingJAMA 2024, meta-analysis (336 pts)Promising. Larger trials would strengthen further.
Anxiety / StressGrowingStress reactivity, PTSD modelsConsistent signal. Some stress measures respond differently.
EpilepsyGrowing4 RCTs, 368 patientsSignificant seizure reduction. Favourable safety profile.
Digestive functionGrowing6 RCTs dyspepsia (716 patients)Moderate-certainty evidence for dyspepsia, QoL improvements.
Cognitive functionEmergingAssociative memory (Jacobs 2015), brain ageing (Trifilio 2023)Promising early results in memory and cognitive ageing. More work needed.

Tones: because one size doesn't fit all

Different therapeutic goals require activation of different nerve fibre subsets. That's why our devices support multiple stimulation Tones -- precision-tuned protocols you load via the Vagal Tones app. From general autonomic rebalancing to targeted digestion and recovery protocols, the science drives the parameters.

Researchers using our Research Edition can create fully custom protocols via the Tone Research Portal.

Ready to feel better?

The science is encouraging. The safety profile is strong. And the people who need it most tend to respond best.

Better starts here

This page summarises published, peer-reviewed research on non-invasive vagus nerve stimulation. We link to original sources so you can read the evidence yourself. We do not claim that our products treat, cure, or prevent any medical condition. If you have a medical concern, please consult your healthcare provider.